|
Market Closed -
NYSE
16:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 5.290 USD | +0.95% |
|
-0.56% | -43.60% |
| 09-10 | Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says | MT |
| 08-31 | Alvotech Shares Rise After FDA Accepts Biologics License Application for AVT80 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALVOTECH | Other Biotechnology & Medical Research | +0.95% | -0.56% | -43.60% | - | -46.13% | 1.89B |  | | |
- Stock Market
- Stocks
- ALVO Stock
- ALVO Stock
- Charts Alvotech
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
